Acasti Pharma Inc Empfehlungs-Mittelwert
Was ist das Empfehlungs-Mittelwert von Acasti Pharma Inc?
Empfehlungs-Mittelwert von Acasti Pharma Inc ist 3.00
Was ist die Definition von Empfehlungs-Mittelwert?
Der empfohlene Mittelwert ist der Durchschnitt der Analystenbewertungen der Aktie von 1,0 (starker Kauf) bis 5,0 (starker Verkauf).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Empfehlungs-Mittelwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acasti Pharma Inc
Was macht Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Unternehmen mit empfehlungs-mittelwert ähnlich Acasti Pharma Inc
- Callon Petroleum Co hat Empfehlungs-Mittelwert von 2.94
- Park Hotels & Resorts Inc hat Empfehlungs-Mittelwert von 2.94
- Hexcel hat Empfehlungs-Mittelwert von 2.95
- Aegon hat Empfehlungs-Mittelwert von 2.95
- Intel hat Empfehlungs-Mittelwert von 2.95
- MGM Resorts International hat Empfehlungs-Mittelwert von 2.95
- Acasti Pharma Inc hat Empfehlungs-Mittelwert von 3.00
- Continental Resources Inc (OKLA) hat Empfehlungs-Mittelwert von 3.03
- Albemarle hat Empfehlungs-Mittelwert von 3.04
- Cognex hat Empfehlungs-Mittelwert von 3.05
- Ventas Inc hat Empfehlungs-Mittelwert von 3.05
- Texas Capital Bancshares hat Empfehlungs-Mittelwert von 3.07
- Pebblebrook Hotel Trust hat Empfehlungs-Mittelwert von 3.07